Orticumab
From WikiMD's WELLNESSPEDIA
| Orticumab | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 1314241-10-5 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.[1]
References[edit]
- ↑ World Health Organization."International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107".WHO Drug Information.2012;26(2)Full text.
| Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
 | This monoclonal antibody–related article is a stub. You can help WikiMD by expanding the page. |
